08/12/2023 19:55 (UTC)

FDA approves first gene-editing technology treatment in the US

Boston (US), Dec 8 (EFE).- The U.S. Food and Drug Administration (FDA) announced on Friday the approval of two treatments for sickle cell disease (SCD), one of which is the first commercially available treatment in the country based on gene-editing technology.

FOOTAGE: VERTEX PHARMACEUTICALS HEADQUARTERS IN BOSTON, MASSACHUSETTS, US.

Camera: CJ Gunther.

Metadata

Date: 08/12/2023 12:00 (UTC)
Credit: EFE
Source: EPA
Topic: Economy, business and finance
Type: Rough cut
Duration: 74 seconds
Reference: 55012485096
Relevance: Normal